Randmized controlled trial to test set-therapy and individualized-therapy for elderly acute myelocytic leukemia

Randmized controlled trial to test set-therapy and individualized-therapy for elderly acute myelocytic leukemia - Randmized controlled trial to test set-therapy and individualized-therapy for elderly acute myelocytic leukemia

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-C000000220

Enrollment

288

Registered

2005-09-20

Start date

2000-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute myelocytic leukemia

Interventions

set therapy individualised therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Previously untreated AML Age between 66 and 80 years Performance status between 0 and 2(ECOG criteria) Serum bilirubin level = 90% Left ventricular ejection fraction >= 50%

Exclusion criteria

Exclusion criteria: History of acute myocardial infarction within 1 year History of renal insuficiancy Poorly controlled diabetes Poorly controleed angina Uncontrolled active infection Liver cirrohsis Severe psychiatric disease Positive for HIV antibody Positive for HCV antibody Positive for HBs antigen

Design outcomes

Primary

Measure	Time frame
complete remission rate, survival period	—

Secondary

Measure	Time frame
over all survival rate, event-free survival	—

Countries

Japan

Contacts

Public ContactAtsushi Wakita, MD

Higashi Municipal Hospital of Nagoya Hematology and Oncology

wakita@higashi-hosp.jp052-721-7171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026